Australia markets closed

Giant Biogene Holding Co., Ltd. (2367.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
49.850-3.100 (-5.85%)
At close: 04:08PM HKT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
1,451,753
1,451,753
1,002,025
828,132
826,450
Depreciation & amortisation
34,175
34,175
27,628
24,210
22,291
Stock-based compensation
20,517
20,517
17,663
16,487
592
Change in working capital
127,813
127,813
-131,671
-57,846
125,390
Inventory
-17,766
-17,766
-94,356
-24,608
-14,443
Other working capital
1,418,998
1,418,998
778,388
581,210
757,793
Other non-cash items
-47,379
-47,379
-13,138
-9,408
-9,882
Net cash provided by operating activities
1,647,431
1,647,431
931,637
692,401
834,124
Cash flows from investing activities
Investments in property, plant and equipment
-228,433
-228,433
-153,249
-111,191
-76,331
Purchases of investments
-1,058,300
-1,058,300
-2,199,176
-3,925,113
-5,084,378
Sales/maturities of investments
678,826
678,826
1,480,529
5,372,324
4,397,435
Net cash used for investing activities
-527,282
-527,282
-858,737
1,563,266
-521,119
Net change in cash
1,171,957
1,171,957
-5,716,866
6,731,211
295,482
Cash at beginning of period
1,330,951
1,330,951
7,103,000
367,805
72,323
Cash at end of period
2,503,999
2,503,999
1,330,951
7,103,000
367,805
Free cash flow
Operating cash flow
1,647,431
1,647,431
931,637
692,401
834,124
Capital expenditure
-228,433
-228,433
-153,249
-111,191
-76,331
Free cash flow
1,418,998
1,418,998
778,388
581,210
757,793